Clinical Trial

Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2021 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Immunocompetent subjects with high load of Epstein-Barr virus DNA (EBV-DNA) in peripheral blood will be enrolled and prospectively followed up to track the natural histories of the chronic high load of EBV virus. The primary goal of this study is to explore the association of peripheral high load of EBV with the hematological malignancies, and second goal is to investigate the genetic mechanisms of immune escape and tumorigenesis of chronic EBV infection.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2018-04-02; most recent amendment 2021-02-09.
Status change: Not Yet Recruiting → Recruiting 2020-03-08
Trial Details
NCT Number NCT03491605
Lead Sponsor Huazhong University of Science and Technology
Conditions EBV Infection
Enrollment 10,000 participants
Start Date 2019-07-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2021-02-10